(lp0
S'Buy or Sell? Average Brokerage Ratings on The Medicines Company (MDCO ... StockNewsJournal - 14 hours ago ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.'
p1
aS'The Medicines Company and Alnylam Pharmaceuticals Report Positive Final ... Yahoo Finance - Mar 17, 2017 The Medicines Company  and Alnylam Pharmaceuticals, Inc.  today announced positive final results from the ORION-1 Phase II study of inclisiran, an investigational, first-in-class PCSK9 synthesis inhibitor being developed for the treatment ...LDL-C Plunges on Novel Anti-PCSK9 Agent Inclisiran: ORION-1 - MedscapeACC: Novel Drug Delivers Long-Term Cholesterol Reduction - MedPage Today'
p2
aS"The Medicines Company to Host Conference Call and Webcast at Upcoming American ... Yahoo Finance - Mar 6, 2017 The Medicines Company  will host a conference call and webcast on Friday, March 17, 2017, at 3:30 p.m., Eastern Time, to review data from the ORION-1 Phase II study of inclisiran, the Company's PCSK9 synthesis inhibitor."
p3
aS"Analysts Near-Term outlook: The Medicines Company , Curis, Inc.  The USA Commerce - Mar 27, 2017 Shares of The Medicines Company  surged 1.40% to $50.69. During the trading on 03/24/2017, Company's stock ranged from $50.94 to $49.69.Recent Trading Updates: The Medicines Company's  - Is storiesNext Weeks Broker Price Targets For The Medicines Company  - Fiscal Standard"
p4
aS'Earnings Reaction History: The Medicines Company, 44.4% Follow-Through ... Nasdaq - Feb 28, 2017 The Medicines Company  is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect light trading in the issue immediately following its quarterly earnings announcement.'
p5
aS'The Medicines Company Partnering Deals and Alliances 2010 to 2017 PR Newswire  - Feb 27, 2017 Chapter 1 provides an introduction to the report, whilst chapter 2 lists the top companies partnering with the company since 2010. Chapter 3 provides an overview of the leading partnering and M&amp;A deals since 2010 to present date based on headline value.'
p6
aS"The Medicines Company to Webcast Presentation of ORION-1 Phase II Study of ... Yahoo Finance - Mar 14, 2017 The Medicines Company  today announced that it will webcast, over the internet simultaneously with the presentation, the detailed results from its ORION-1 Phase II study of inclisiran, the Company's PCSK9 synthesis inhibitor, featured in the&nbsp;..."
p7
aS'The Medicines Company Reports Fourth-Quarter and Full-Year 2016 Financial Results Yahoo Finance - Feb 28, 2017 Driven by strong execution against our strategic priorities, 2016 was a transformative year for the Company, said Clive Meanwell, M.D.'
p8
aS"Today's Analyst Moves: The Medicines Company , Cal-Maine Foods, Inc.  USA Commerce Daily - Mar 28, 2017 Shares of The Medicines Company  are making a strong comeback as they have jumped 72.69% since bottoming out at $29.48 on Mar. 29, 2016."
p9
aS'The Medicines Company  Breaks into New 52-Week High on March 16 Session Equities.com - Mar 16, 2017 Shares of The Medicines Company  broke into a new 52-week high yesterday, hitting a peak of $55.28. Shares closed at $52.58 after opening at $55.00 for a move of -3.36%.Taking a Look at the Data Behind The Medicines Company  - StockNewsJournalThe Medicines Company  Files An 8-K Other Events - Market Exclusive'
p10
a.